Multiple hyperthermia-mediated release of TRAIL/SPION nanocomplex from thermosensitive polymeric hydrogels for combination cancer therapy.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) possesses strong anti-cancer potential because of its ability to specifically kill cancer cells. However, clinical use of TRAIL is impeded by its short in vivo half-life and native TRIAL-resistant cancer cell populations. To overcome these limitations, we designed a multiple magnetic hyperthermia (MHT)-mediated TRAIL release system for combination therapy using an injectable, biodegradable and thermosensitive polymeric hydrogel. In this system, positively charged TRAIL and hydrophobic superparamagnetic iron oxide nanoparticles (SPIONs) are complexed with negatively charged poly(organophosphazene) polymers via ionic and hydrophobic interactions, respectively. Transmission electron microscopy images showed a nano-sized core-shell structure of the TRAIL/SPION polymeric nanocomplex in aqueous solution that transformed into a hydrogel at body temperature. Hyperthermia can enhance the release of TRAIL from hydrogels through temperature-sensitive hydrogel dissolution. TRAIL-resistant U-87 MG cells were killed by the combination of TRAIL and multiple hyperthermia via caspase-3 and -8 active apoptosis. The hyperthermia-enhanced cytotoxicity of TRAIL was dependent on the hyperthermia cycle number and corresponding TRAIL release. Significant in vivo tumor reduction was observed by combining 2 cycles of mild MHT and TRAIL release using a single injection of TRAIL/SPION nanocomplex hydrogels without damage to main organs. Furthermore, the therapeutic outcomes can be monitored by long-term magnetic resonance imaging.

[1]  Sung Tae Kim,et al.  Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. , 2007, Angewandte Chemie.

[2]  Eun Seong Lee,et al.  Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. , 2012, Biomaterials.

[3]  Sang Beom Lee,et al.  A New Class of Biodegradable Thermosensitive Polymers. 2. Hydrolytic Properties and Salt Effect on the Lower Critical Solution Temperature of Poly(organophosphazenes) with Methoxypoly(ethylene glycol) and Amino Acid Esters as Side Groups , 1999 .

[4]  Tianyue Jiang,et al.  Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots. , 2016, Nano letters.

[5]  Hao Zeng,et al.  Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.

[6]  H. Wakimoto,et al.  Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Jinwoo Cheon,et al.  Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. , 2009, Angewandte Chemie.

[8]  J. Beck,et al.  Differential responsiveness of human hepatoma cells versus normal hepatocytes to TRAIL in combination with either histone deacetylase inhibitors or conventional cytostatics , 2008, Cancer science.

[9]  X. Song,et al.  Hyperthermia enhances mapatumumab-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP(long) in human colon cancer cells , 2013, Cell Death and Disease.

[10]  Xiaoyuan Chen,et al.  Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles. , 2011, Biomaterials.

[11]  J. Vose,et al.  A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma , 2010, British Journal of Cancer.

[12]  N. Clemons,et al.  TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression , 2006, Cell stress & chaperones.

[13]  Kwangmeyung Kim,et al.  Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis. , 2010, Biomaterials.

[14]  B. Lee,et al.  Synthesis and characterization of biodegradable Thermosensitive poly(organophosphazene) gels , 2004 .

[15]  A. Letai,et al.  Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis , 2013, Apoptosis.

[16]  Roberto Cingolani,et al.  Controlled release of doxorubicin loaded within magnetic thermo-responsive nanocarriers under magnetic and thermal actuation in a microfluidic channel. , 2012, ACS nano.

[17]  G. Dranoff,et al.  Cytokines in cancer pathogenesis and cancer therapy , 2004, Nature Reviews Cancer.

[18]  Soo-Chang Song,et al.  Thermosensitive/superparamagnetic iron oxide nanoparticle-loaded nanocapsule hydrogels for multiple cancer hyperthermia. , 2016, Biomaterials.

[19]  J. Z. Hilt,et al.  Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Yuhua Wang,et al.  A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA. , 2016, Biomaterials.

[21]  Seong Ho Choi,et al.  Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer. , 2014, Acta biomaterialia.

[22]  Eun Seong Lee,et al.  In situ facile-forming PEG cross-linked albumin hydrogels loaded with an apoptotic TRAIL protein. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[23]  T. Yen,et al.  Non‐Invasive Synergistic Treatment of Brain Tumors by Targeted Chemotherapeutic Delivery and Amplified Focused Ultrasound‐Hyperthermia Using Magnetic Nanographene Oxide , 2013, Advanced materials.

[24]  Z. Ronai,et al.  Death receptors and melanoma resistance to apoptosis , 2003, Oncogene.

[25]  A. Arrigo,et al.  Caspases activation in hyperthermia-induced stimulation of TRAIL apoptosis , 2008, Cell Stress and Chaperones.

[26]  E. Schacht,et al.  Synthesis and Evaluation of the Hydrolytical Stability of Ethyl 2‐(α‐Amino acid)Glycolates and Ethyl 2‐(α‐Amino Acid)Lactates , 2010 .

[27]  H. Ford,et al.  On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics , 2013, Oncogene.

[28]  S. Dutz,et al.  Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy , 2007 .

[29]  M. Smyth,et al.  Cytokines in cancer immunity and immunotherapy , 2004, Immunological reviews.

[30]  Xiaojing Tang,et al.  Novel Conjugation of Tumor‐Necrosis‐Factor‐Related Apoptosis‐Inducing Ligand (TRAIL) with Monomethyl Auristatin E for Efficient Antitumor Drug Delivery , 2013, Advanced materials.

[31]  J. Cheon,et al.  Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. , 2013, Angewandte Chemie.

[32]  Marina Temchenko,et al.  Self-Assembly in Aqueous Solutions of Poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)-b-poly(vinyl alcohol) , 1999 .

[33]  Guo Gao,et al.  Establishment of a method to determine the magnetic particles in mouse tissues , 2012, Nanoscale Research Letters.

[34]  Liberato Manna,et al.  Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. , 2012, ACS nano.

[35]  C. Garrido,et al.  Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion , 2015, Cell Death and Disease.

[36]  Shuqing Chen,et al.  Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). , 2013, Biomaterials.

[37]  David E. Golan,et al.  Protein therapeutics: a summary and pharmacological classification , 2008, Nature Reviews Drug Discovery.

[38]  R. Weissleder,et al.  A Novel Molecule Integrating Therapeutic and Diagnostic Activities Reveals Multiple Aspects of Stem Cell‐based Therapy , 2010, Stem cells.

[39]  Tatsushi Yoshida,et al.  Repeated Treatment with Subtoxic Doses of TRAIL Induces Resistance to Apoptosis through Its Death Receptors in MDA-MB-231 Breast Cancer Cells , 2009, Molecular Cancer Research.

[40]  Pallab Pradhan,et al.  Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[41]  A. Ashkenazi,et al.  Directing cancer cells to self-destruct with pro-apoptotic receptor agonists , 2008, Nature Reviews Drug Discovery.

[42]  Soo-Chang Song,et al.  MRI-monitored long-term therapeutic hydrogel system for brain tumors without surgical resection. , 2012, Biomaterials.

[43]  Frank Y. S. Chuang,et al.  Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. , 2009, Cancer research.

[44]  M. Rehm,et al.  TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies , 2012, Molecular Cancer Therapeutics.

[45]  M. Berger,et al.  mTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme Cells , 2005, Molecular and Cellular Biology.

[46]  Erkki Ruoslahti,et al.  Remotely Triggered Release from Magnetic Nanoparticles , 2007 .

[47]  El‐Shaimaa A. Arafa,et al.  Sensitization of Hepatocellular Carcinoma Cells to Apo2L/TRAIL by a Novel Akt/NF‐κB Signalling Inhibitor , 2014, Basic & clinical pharmacology & toxicology.

[48]  Yong Sun,et al.  PARP-1 Regulates Resistance of Pancreatic Cancer to TRAIL Therapy , 2013, Clinical Cancer Research.

[49]  T. Minko,et al.  Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer. , 2016, Biomaterials.

[50]  T. Gharbi,et al.  Nanovectorization of TRAIL with single wall carbon nanotubes enhances tumor cell killing. , 2015, Nano letters.

[51]  J. Wolchok,et al.  Antibody therapy of cancer , 2012, Nature Reviews Cancer.

[52]  M. Leverkus,et al.  Crystal Violet Assay for Determining Viability of Cultured Cells. , 2016, Cold Spring Harbor protocols.

[53]  I. Buchan,et al.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. , 2006, JAMA.

[54]  M. Park,et al.  Injectable polyplex hydrogel for localized and long-term delivery of siRNA. , 2012, ACS nano.

[55]  S. Strom,et al.  Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.

[56]  Mark J. Smyth,et al.  The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.

[57]  Y. Byun,et al.  PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[58]  Gagandeep Kaur,et al.  Structurally engineered anodic alumina nanotubes as nano-carriers for delivery of anticancer therapeutics. , 2014, Biomaterials.